$TARS Tarsus Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tarsus Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Tarsus Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Tarsus Pharmaceuticals, Inc. for free.
IRS Number: 814717861
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: TARS
Company Address: 15440 LAGUNA CANYON ROAD IRVINE 92618
Tarsus Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | TARS | Tarsus Pharmaceuti ... | YARNO WENDY L | Director | Option Exercise | A | 35.26 | 5,000 | 176,300 | 5,000 | |
| Jun 17 2021 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | A | 35.26 | 10,000 | 352,600 | 10,000 | |
| Jun 17 2021 | TARS | Tarsus Pharmaceuti ... | Tester Jason E. | Director | Option Exercise | A | 35.26 | 10,000 | 352,600 | 10,000 | |
| May 07 2021 | TARS | Tarsus Pharmaceuti ... | RTW INVESTMENTS, LP | 10% Owner | Sell | S | 29.98 | 450,000 | 13,491,000 | 2,013,601 | 2.5 M to 2 M (-18.27 %) |
| Apr 16 2021 | TARS | Tarsus Pharmaceuti ... | Vivo Capital IX, LLC | 10% Owner | Sell | S | 30.37 | 400 | 12,148 | 3,244,635 | 3.2 M to 3.2 M (-0.01 %) |
| Mar 04 2021 | TARS | Tarsus Pharmaceuti ... | Holdbrook Mark J. | V.P., Clinical Affa ... | Option Exercise | A | 34.72 | 14,300 | 496,496 | 14,300 | |
| Feb 02 2021 | TARS | Tarsus Pharmaceuti ... | Wahl Bryan | General Counsel | Option Exercise | A | 37.44 | 89,368 | 3,345,938 | 89,368 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Greenstein Leonard M. | Chief Financial Off ... | Option Exercise | A | 47.25 | 40,999 | 1,937,203 | 40,999 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Neervannan Seshadri | Chief Operating Off ... | Option Exercise | A | 47.25 | 61,499 | 2,905,828 | 61,499 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Mottiwala Aziz | Chief Commercial Of ... | Option Exercise | A | 47.25 | 40,999 | 1,937,203 | 40,999 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Azamian Bobak R. | President and CEO | Option Exercise | A | 47.25 | 204,998 | 9,686,156 | 204,998 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Whitfield Dianne C. | Chief Human Resourc ... | Option Exercise | A | 47.25 | 89,368 | 4,222,638 | 89,368 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Azamian Bobak R. | President and CEO | Option Exercise | A | 47.25 | 204,998 | 9,686,156 | 204,998 | |
| Jan 08 2021 | TARS | Tarsus Pharmaceuti ... | Whitfield Dianne C. | Chief Human Resourc ... | Option Exercise | A | 47.25 | 89,368 | 4,222,638 | 89,368 | |
| Nov 23 2020 | TARS | Tarsus Pharmaceuti ... | YARNO WENDY L | Director | Option Exercise | A | 23.40 | 20,000 | 468,000 | 20,000 |